Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Novozymes Biopharma AB

BioPhotonics
Apr 2009
Novozymes Biopharma AB of Lund, Sweden, and Upperton Ltd. of Nottingham, UK, have been granted a European patent for their targeted drug delivery technology. The patent describes methods of conjugating antibodies and other targeting agents to protein carriers by using a heterobifunctional linker, making it possible to deliver large quantities of drugs to selected sites in the body.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!